Azuma Mitsuyoshi, Tamada Yoshiyuki, Kanaami Sayaka, Nakajima Emi, Nakamura Yoshikuni, Fukiage Chiho, Forsberg Neil E, Duncan Melinda K, Shearer Thomas R
Research Laboratory, Senju Pharmaceutical Corporation Limited, Kobe 651-2241, Japan.
Biochem Biophys Res Commun. 2003 Aug 1;307(3):558-63. doi: 10.1016/s0006-291x(03)01194-x.
The purpose of the present study was to compare the susceptibility of crystallins proteolyzed by ubiquitous calpain 2 and by lens-specific calpain Lp82 to insolubilization. To test this, transgenic (TG) mice expressing a calpain 2, in which the active site cysteine 105 was mutated to alanine, were produced. Expression of mutated calpain 2 was driven in lens by coupling the mutated gene to the betaB1-crystallin promoter. Light scattering was measured in solutions of lens proteins after activation of endogenous calpain 2 and/or Lp82. Mass spectrometric analysis was performed to determine the cleavage sites and the calpain responsible for insolubilization of crystallins. Lens proteins from TG mice incubated in vitro with calcium showed higher light scattering compared to proteins from wild type (WT) mice. alphaA-crystallin from TG mice was proteolyzed by Lp82. In contrast, alphaA-crystallin in lenses from WT mice were proteolyzed by both calpain 2 and Lp82. These results suggested that Lp82-induced proteolysis of crystallins caused increased susceptibility of truncated crystallins to in vitro precipitation. Since Lp82 is highest in young animals, Lp82-induced proteolysis and precipitation may be one of the factors responsible for the cataract formation in young rodents.
本研究的目的是比较由普遍存在的钙蛋白酶2和晶状体特异性钙蛋白酶Lp82蛋白水解的晶状体蛋白发生不溶性化的敏感性。为了对此进行测试,制备了表达钙蛋白酶2的转基因(TG)小鼠,其中活性位点半胱氨酸105突变为丙氨酸。通过将突变基因与βB1 - 晶状体蛋白启动子偶联,在晶状体中驱动突变钙蛋白酶2的表达。在内源性钙蛋白酶2和/或Lp82激活后,测量晶状体蛋白溶液中的光散射。进行质谱分析以确定裂解位点以及负责晶状体蛋白不溶性化的钙蛋白酶。与来自野生型(WT)小鼠的蛋白质相比,在体外与钙一起孵育的TG小鼠的晶状体蛋白显示出更高的光散射。来自TG小鼠的αA - 晶状体蛋白被Lp82蛋白水解。相比之下,WT小鼠晶状体中的αA - 晶状体蛋白被钙蛋白酶2和Lp82两者蛋白水解。这些结果表明,Lp82诱导的晶状体蛋白水解导致截短的晶状体蛋白在体外沉淀的敏感性增加。由于Lp82在幼小动物中含量最高,Lp82诱导的蛋白水解和沉淀可能是导致幼龄啮齿动物白内障形成的因素之一。